Federal workers get overdose kits; private employers just get a suggestion

What it does

This bill requires the Department of Labor to issue non-binding guidance to private employers on acquiring opioid overdose reversal medication (like naloxone) and training employees to use it, and to issue binding regulations requiring all federal agencies to do the same within 270 days. Private employers are encouraged but not required; federal agencies must comply.

Why we flagged it

The bill's operative mechanism is a straightforward public-health mandate: requiring federal agencies and encouraging private employers to stock and train on overdose reversal medication. This is a workplace safety measure aimed at reducing opioid-related deaths.

What the text implies

• Federal agencies must bear the cost of acquiring and maintaining naloxone/overdose reversal medication indefinitely, with no appropriation specified — implementation cost falls on agency budgets.
• Annual training requirement for all federal employees may create administrative burden and compliance tracking obligations across thousands of agencies.
• Non-mandatory guidance to private employers may create liability exposure if employers adopt the guidance but fail to maintain stock or train adequately, potentially inviting negligence claims.
• Exclusion of USPS from private-employer guidance may reflect prior statutory carve-outs but creates an inconsistency: postal workers are excluded from the voluntary program despite working in a federal-adjacent environment.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Employees in federal agencies gain a guaranteed right to access overdose reversal medication and training, potentially saving lives in overdose emergencies. Private-sector employees benefit from employer guidance that may lead to voluntary adoption of the same protections, though without legal mandate. No citizen loses rights or protections.

Who stands to gain

• pharmaceutical manufacturers of naloxone and overdose reversal medications
• workplace safety training providers and consultants
• occupational health and safety equipment suppliers

Named in the bill

Secretary of Labor, Occupational Safety and Health Administration (OSHA), Federal agencies, Veterans Health Administration, United States Postal Service, Occupational Safety and Health Act of 1970

Where it stands

5 cosponsors: 4 Democrats, 1 Republicans.

• Feb 10, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Feb 10, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
• Mar 19, 2026 — Hearing held · Congress.gov: “Committee on Health, Education, Labor, and Pensions. Hearings held”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

3 lobbying clients named this bill on 3 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $210,555 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 61% of bills with at least one filing.

Jeff Merkley, the sponsor, reported $514,925 in PAC receipts in the 2026 cycle.

• National Council for Behavioral Health — $150,555 on 1 filing
• Tobacco-free Kids Action Fund Fka Global Health Advocacy Incubator (ghai) — $40,000 on 1 filing
• Kelley Drye & Warren Llp Obo Tobacco-free Kids Action Fund — $20,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.